In a few days the global cyclodextrin community gathers in Dunkerque to share thoughts, and results, discuss collaborations and renew friendships.
From CarboHyde‘s perspective, there are several lectures that we look forward to with great excitement:
- Francesco Stellacci – our long time collaborator from EPFL , pioneer of using cyclodextrins as antiviral compounds, founder of asterivir
- Matthew “Oki” O’Connor – CEO of Cyclarity Therapeutics , a close partner of us doing groundbreaking science of using CDs in atherosclerosis
- Tamas Sohajda – CarboHyde CEO delivers a review on using cyclodextrins as active ingredients
- Julien Parcq & Damien TRUFFIN – from Roquette, our key partner in cyclodextrin education, discussing critical attributes of CD manufacturing & safety
- Milo Malanga PhD – CarboHyde CSO sharing from synthetic challenges
- Juan Manuel Benito – Bicyclos HEurope partner, expert in using CDs for gene delivery
- Caitriona O’Driscoll – GENEGUT coordinator, an expert in using CDs for gene delivery
- Francesco Trotta & Adrián Matencio Durán, our research partners on nanosponges from University of Turin
- Szabolcs Béni – from CarboHyde advisory board and BiCyclos member from Eötvös Loránd University, an expert on CD NMR and analysis
- Ilse Manet – BiCyclos coordinator, an expert in CD analysis and applications
And this is just the tip of the iceberg.
